{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T12:09:33Z","timestamp":1785326973571,"version":"3.55.0"},"reference-count":37,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Immunity Inflam &amp;amp; Disease"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Type 2 diabetes mellitus (T2D) is a prevalent chronic disease characterized by pancreatic \u03b2\u2010cell loss induced by hyperglycemia. Effective treatments to repair \u03b2\u2010cell damage remain unclear. Hyperoside, a flavonoid glycoside with diverse pharmacological effects, has rarely been studied in H\n                      <jats:sub>2<\/jats:sub>\n                      O\n                      <jats:sub>2<\/jats:sub>\n                      \u2010induced \u03b2\u2010cell injury, and its mechanisms are unknown.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      To explore the protective effects of hyperoside on H\n                      <jats:sub>2<\/jats:sub>\n                      O\n                      <jats:sub>2<\/jats:sub>\n                      \u2010induced pancreatic \u03b2\u2010cell damage and its underlying mechanisms.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      RIN\u2010m5F cells were pretreated with 0, 25, 50, 100\u2009\u03bcM hyperoside or 5\u2009\u03bcM ML385 (inhibitor of the\n                      <jats:italic>Nrf2\/HO\u20101<\/jats:italic>\n                      pathway) for 48\u2009h, followed by 100\u2009\u03bcmol\/ml H\n                      <jats:sub>2<\/jats:sub>\n                      O\n                      <jats:sub>2<\/jats:sub>\n                      for another 30\u2009min. MTT assay and flow cytometry were used to assess cell viability and apoptotic cells. The activities of ROS, CAT, SOD, GSH\u2010PX, and MDA were measured using the corresponding assay kits. The levels of apoptosis\u2010related proteins, including cleaved\u2010caspase3 and caspase\u20103, were determined by western blotting. A glucose\u2010stimulated insulin secretion (GSIS) assay was used to assess insulin secretion. Reverse\u2010transcription quantitative PCR (RT\u2010qPCR) and western blotting were used to measure the expression of\n                      <jats:italic>Nrf2<\/jats:italic>\n                      and\n                      <jats:italic>HO\u20101<\/jats:italic>\n                      in the\n                      <jats:italic>Nrf2\/HO\u20101<\/jats:italic>\n                      pathway.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Hyperoside (0, 25, 50, 100\u2009\u03bcM) showed no toxic side effects on RIN\u2010m5F cells. H\n                      <jats:sub>2<\/jats:sub>\n                      O\n                      <jats:sub>2<\/jats:sub>\n                      reduced RIN\u2010m5F cell viability, increased apoptosis, elevated ROS\/MDA, decreased antioxidant enzyme activities, suppressed insulin secretion, and downregulated Nrf2\/HO\u20101. Hyperoside pretreatment reversed these effects, improving viability, reducing apoptosis, restoring antioxidant activity, enhancing insulin secretion, and upregulating Nrf2\/HO\u20101. ML385 abolished hyperoside's protective effects.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Hyperoside protects pancreatic \u03b2\u2010cells against oxidative stress and apoptosis by activating the Nrf2\/HO\u20101 pathway. It may serve as a potential therapeutic agent for preventing \u03b2\u2010cell damage in T2D.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/iid3.70480","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T03:24:16Z","timestamp":1783481056000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Protective Effects of Hyperoside on Type 2 Diabetes Through the Regulation of Pancreatic \u03b2\u2010cell Function"],"prefix":"10.1002","volume":"14","author":[{"given":"Yuanyuan","family":"Jia","sequence":"first","affiliation":[{"name":"Department of Endocrinology The Third Affiliated Hospital of Qiqihar Medical University Qiqihar China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yincui","family":"Ai","sequence":"additional","affiliation":[{"name":"Department of Nursing Gannan County People's Hospital Qiqihar China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8370-8413","authenticated-orcid":false,"given":"Fei","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Endocrinology The Third Affiliated Hospital of Qiqihar Medical University Qiqihar China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"e_1_2_10_2_1","volume-title":"Type 2 Diabetes","author":"Goyal R.","year":"2026"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqad134"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-022-00618-5"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10517-021-05191-7"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2158644"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-022-03776-w"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3182931"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27093009"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21010131"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.7900"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.733808"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12011-021-02784-1"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102852"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.7749"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110501"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1006\/meth.2001.1262"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2020.11548"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27030950"},{"key":"e_1_2_10_20_1","volume-title":"IDF Diabetes Atlas","author":"International Diabetes Federation","year":"2025"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01512-w"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22041509"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.acthis.2019.07.005"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-021-03404-z"},{"issue":"2","key":"e_1_2_10_25_1","first-page":"617","article-title":"Hyperoside Exhibits Anticancer Activity in Non\u2011Small Cell Lung Cancer Cells With T790M Mutations by Upregulating FoxO1 via CCAT1","volume":"43","author":"Hu Z.","year":"2020","journal-title":"Oncology Reports"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphs.2021.02.005"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/1028415X.2021.1901047"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20235832"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00159-24"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102460"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3999083"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12088-023-01065-w"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40659-019-0242-7"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-023-07522-4"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-022-08046-0"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04478-x"},{"issue":"5","key":"e_1_2_10_37_1","first-page":"673","article-title":"Hyperoside Protects Mouse Spermatocytes GC\u20102 Cells From Oxidative Damage by Activating the Keap1\/Nrf2\/HO\u20101 Pathway","volume":"42","author":"Zhu Y.","year":"2022","journal-title":"Journal of Southern Medical University"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.01065"}],"container-title":["Immunity, Inflammation and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/iid3.70480","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/iid3.70480","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/iid3.70480","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:51:31Z","timestamp":1785325891000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/iid3.70480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1002\/iid3.70480"],"URL":"https:\/\/doi.org\/10.1002\/iid3.70480","archive":["Portico"],"relation":{},"ISSN":["2050-4527","2050-4527"],"issn-type":[{"value":"2050-4527","type":"print"},{"value":"2050-4527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"2025-06-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70480"}}